Year: 2007
Notification procedure for the Deliberate release into the environment of genetically modified crops for purposes other than placing on the market – Field trials in accordance with Article 14 of the GMO (Deliberate Release) Regulations S.I. No 500 of 2003
Year: 2002
The GMO Register Entry G0134-01 provides significant details of the clinical trial.
Year: 2002
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in his report to the Board of the Agency.
Year: 2002
Consent Conditions G0134-01 issued to Schering Healthcare Limited for a clinical trial on patients suffering from angina pectoris, using a Genetically Modified Organism (GMO).
Year: 2002
Summary Notification Information Format (SNIF) for the release of genetically modified organisms other than higher plants (Part B, clinical trials)
Year: 2002
Summary Notification Information Format (SNIF) for the release of genetically modified higher plants (Angiospermae and Gymnospermae)(Part B, field trials)
Year: 2001
There is a statutory requirement for users of GM animals to apply the principles of Good Animal House Practice. These guidelines are for GMO users who plan to work with GM animals in animal houses.
Year: 2001
These are guidelines for users who plan to work with GM plants in greenhouses, growthrooms, growth cabinets etc. The regulations require GMO users to 'apply principles of good greenhouse, growthroom practice, including such principles (if any) as may be specified or approved by the Agency.'
